Skandinaviska Enskilda Banken AB publ Has $11.92 Million Stake in Agilent Technologies, Inc. (NYSE:A)

Skandinaviska Enskilda Banken AB publ lifted its stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) by 56.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 88,695 shares of the medical research company's stock after buying an additional 32,012 shares during the quarter. Skandinaviska Enskilda Banken AB publ's holdings in Agilent Technologies were worth $11,922,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently added to or reduced their stakes in the company. CKW Financial Group increased its stake in Agilent Technologies by 114.9% during the fourth quarter. CKW Financial Group now owns 187 shares of the medical research company's stock valued at $25,000 after purchasing an additional 100 shares during the last quarter. Global X Japan Co. Ltd. increased its stake in Agilent Technologies by 161.1% during the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company's stock valued at $25,000 after purchasing an additional 116 shares during the last quarter. Ashton Thomas Securities LLC bought a new stake in Agilent Technologies during the third quarter valued at $31,000. Hanson & Doremus Investment Management increased its stake in Agilent Technologies by 66.5% during the fourth quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company's stock valued at $35,000 after purchasing an additional 105 shares during the last quarter. Finally, OFI Invest Asset Management bought a new stake in Agilent Technologies during the fourth quarter valued at $37,000.

Agilent Technologies Price Performance

NYSE A traded down $0.83 on Wednesday, reaching $122.27. The company's stock had a trading volume of 1,405,863 shares, compared to its average volume of 1,856,572. Agilent Technologies, Inc. has a twelve month low of $117.17 and a twelve month high of $155.35. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20. The stock has a market cap of $34.86 billion, a PE ratio of 28.11, a PEG ratio of 3.44 and a beta of 1.11. The firm's 50 day moving average is $137.70 and its two-hundred day moving average is $137.68.

Remove Ads

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, beating analysts' consensus estimates of $1.27 by $0.04. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. The company had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. As a group, sell-side analysts predict that Agilent Technologies, Inc. will post 5.57 EPS for the current year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st will be issued a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a yield of 0.81%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies's payout ratio is 22.76%.

Analysts Set New Price Targets

Several research firms have recently commented on A. Barclays upgraded shares of Agilent Technologies from an "underweight" rating to an "equal weight" rating and upped their price target for the stock from $135.00 to $145.00 in a research report on Monday, February 10th. Citigroup upped their price target on shares of Agilent Technologies to $165.00 and gave the stock a "buy" rating in a research report on Thursday, December 19th. StockNews.com upgraded shares of Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Tuesday, December 24th. Wells Fargo & Company lowered their price target on shares of Agilent Technologies from $157.00 to $155.00 and set an "overweight" rating for the company in a research report on Monday, December 9th. Finally, Bank of America lowered their price target on shares of Agilent Technologies from $153.00 to $150.00 and set a "neutral" rating for the company in a research report on Friday, December 13th. Seven equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to data from MarketBeat, Agilent Technologies has an average rating of "Moderate Buy" and an average price target of $146.15.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, VP Rodney Gonsalves sold 1,908 shares of the business's stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the sale, the vice president now owns 21,786 shares in the company, valued at approximately $2,657,456.28. The trade was a 8.05 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Padraig Mcdonnell sold 1,911 shares of the business's stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the sale, the chief executive officer now owns 39,652 shares in the company, valued at approximately $5,947,800. The trade was a 4.60 % decrease in their position. The disclosure for this sale can be found here.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.